Maxcyte (MXCT) Change in Receivables (2020 - 2026)
Maxcyte (MXCT) posted quarterly Change in Receivables of $743000.0 for Q1 2026, down 11.44% year-over-year from $839000.0 in Q1 2025, and up 115.49% quarter-over-quarter from -$4.8 million in Q4 2025.
Maxcyte (MXCT) Change in Receivables (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has reported Change in Receivables for 7 consecutive years, with $743000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables fell 11.44% year-over-year to $743000.0; the TTM figure through Mar 2026 stood at -$1.2 million (down 70.41% YoY), while the FY2025 annual figure was -$1.1 million, up 6.36% from the prior year.
- Change in Receivables grew to $743000.0 in Q1 2026 per MXCT's latest filing, from -$4.8 million in the prior quarter.
- Across five years, Change in Receivables topped out at $4.0 million in Q4 2022 and bottomed at -$4.8 million in Q4 2025.
- Historically, Change in Receivables has averaged -$134588.2 across 5 years, with a median of $122000.0 in 2024.
- Annual changes were most pronounced in 2023 — Change in Receivables jumped 46455.56% — and 2025, when it tumbled 4031.97%.
- Maxcyte's Change in Receivables stood at $4.0 million in 2022, then sank by 141.25% to -$1.7 million in 2023, then soared by 107.37% to $122000.0 in 2024, then sank by 4031.97% to -$4.8 million in 2025, then surged by 115.49% to $743000.0 in 2026.
- Business Quant data shows MXCT's Change in Receivables at $743000.0 in Q1 2026, -$4.8 million in Q4 2025, and $2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | - |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Maxcyte | 147.95 Mn | 147.95 Mn | 5.60 Mn | -324,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -324,000.00 |
| Jun 30, 2026 | -324,000.00 |
| Mar 31, 2026 | 743,000.00 |
| Mar 31, 2026 | 743,000.00 |
| Dec 31, 2025 | -4.80 Mn |
| Dec 31, 2025 | -4.80 Mn |
| Sep 30, 2025 | 2.57 Mn |
| Sep 30, 2025 | 2.57 Mn |
| Jun 30, 2025 | 238,000.00 |
| Jun 30, 2025 | 238,000.00 |
| Mar 31, 2025 | 839,000.00 |
| Mar 31, 2025 | 839,000.00 |
| Dec 31, 2024 | 122,000.00 |
| Dec 31, 2024 | 122,000.00 |
| Sep 30, 2024 | -21,000.00 |
| Sep 30, 2024 | -21,000.00 |
| Jun 30, 2024 | -1.67 Mn |
| Jun 30, 2024 | -1.67 Mn |
| Mar 31, 2024 | 343,000.00 |
| Mar 31, 2024 | 343,000.00 |